A carregar...
IMMU-22. COMBINATION IMMUNOTHERAPY WITH IDO1 INHIBITION ENHANCES TREATMENT EFFICACY IN MULTIPLE MODELS OF GLIOBLASTOMA MODEL
Progress in improving outcomes for glioblastoma (GBM) patients has been modest at best. Despite maximum surgical resection, radiotherapy (RT), and chemotherapy, the combination of which is considered the best treatment for GBM, median overall survival (OS) is only approximately 15 months. Treatment...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692829/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.480 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|